- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Pharmaceutical Research Network
Total 2626 results
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaBelgium, Germany, Russian Federation, Slovakia, Sweden
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBipolar DisorderUnited States, Ukraine, Taiwan, Spain, Poland, India, Malaysia, Russian Federation, Slovakia, Austria
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHeart FailureBelgium, Germany, Poland, Romania
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedRheumatoid ArthritisUnited States, Germany
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSexual Dysfunction | Erectile DysfunctionFrance, Poland, United States, Belgium, Mexico, Malaysia, Canada, Taiwan, Korea, Republic of, Russian Federation, Argentina, Australia, United Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedVentilator-Associated PneumoniaUnited States, Australia, Germany, France, Spain, Argentina, Mexico, Portugal, India, Romania, Turkey, Ukraine, Canada, Belgium, Brazil, Philippines, Russian Federation, Hungary, Israel, Thailand, Guatemala
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMild Cognitive ImpairmentUnited States, United Kingdom, Belgium, Germany, Spain, Argentina, Israel, Poland, Australia, Canada, Netherlands, Finland, Austria, Sweden, France, Czech Republic
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMood Disorders | Bipolar Disorders | Affective Disorders, Psychotic
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia | Schizoaffective Disorder
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDementia | Alzheimer Disease
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedEpilepsy | Seizures | Epilepsies, Partial
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedEpilepsy | Epilepsy, Generalized | Seizures | Epilepsies, Partial | Epilepsy, Tonic-Clonic
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedEpilepsy | Seizures | Epilepsies, Partial
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHealthy | Pharmacokinetics | Drug Interactions
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedA Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver FunctionSchizophrenia | Hepatic Impairment
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDementia | Alzheimer Disease
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPsychotic Disorders | Schizophrenia
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSexual Dysfunction | Ejaculation
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorders
-
Johnson & Johnson Pharmaceutical Research & Development...Completed